Above: A Nexstar video breaking down how much states make on marijuana sales.
SAN DIEGO (FOX 5/KUSI) — A compound in cannabis may offer a novel treatment solution for neurological disorders like Alzheimer’s or Parkinson’s, according to a new study from the Salk Institute for Biological Studies.
The La Jolla-based researchers began exploring whether a milder, less psychoactive type of cannabinoid, which are compounds derived from the cannabis plant, can have a therapeutic or clinical application.
The cannabinoid is called cannabinol (CBN) — a cousin of the more well-known compounds: tetrahydrocannabinol (THC) and cannabidiol (CBD). The chemical is found in the sativa strain of the cannabis plant. What is delta-8? What to know about the alternative THC products and their use by teens What the Salk Institute’s researchers found is that this chemical can be developed for use to protect the brain from aging and neurodegeneration, suggesting promise for CBN in treating conditions like a traumatic brain injury, Alzheimer’s and Parkinson’s.
These conclusions were published in the science journal, Redox Biology , last month.
“Not only does CBN have neuroprotective properties, but its derivatives have the potential to become novel therapeutics for various neurological disorders,” Pamela Maher , senior author of the study and Salk Institute research professor, said in a release. TOP STORIES
According to Salk, researchers already knew that CBN had a degree of neuroprotective abilities by preventing brain cells’ mitochondria, which generates power, from becoming dysfunctional. Without a functioning mitochondria, these brain cells, known as neurons, die.To understand whether […]
Cannabis compound may offer treatment for brain disorders: study
